Oragenics
OGEN
17 hedge funds and large institutions have $6.63M invested in Oragenics in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 10 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
20% less capital invested
Capital invested by funds: $8.27M → $6.63M (-$1.64M)
26% less funds holding
Funds holding: 23 → 17 (-6)
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$374K |
| 2 |
State Street
Boston,
Massachusetts
|
+$332K |
| 3 |
Renaissance Technologies
New York
|
+$184K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$142K |
| 5 |
VF
Virtu Financial
New York
|
+$31.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$336K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$225K |
| 3 |
BlackRock
New York
|
-$201K |
| 4 |
PWAC
Private Wealth Advisors (California)
Fresno,
California
|
-$52K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$44K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TSS
26
Two Sigma Securities
New York
| – | -$10K | -6 | Closed |
|
|
WAP
27
Wealthcare Advisory Partners
West Chester,
Pennsylvania
| – | -$5K | -3 | Closed |
|
28
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$3K | -2 | Closed |
|
29
Barclays
London,
United Kingdom
| – | -$1K | – | – |
|
OGEN Hedge Fund Activity: Q2 2021 in Review
17 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q2 2021, worth a combined $6.63M — down 20% from $8.27M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of OGEN and 4 opened new positions — a net loss of 6 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Vanguard Group, adding an estimated $374K. The largest seller was Citadel Advisors, exiting entirely with an estimated $336K sold.
- 17 institutional investors held Oragenics (OGEN) as of Q2 2021, down from 23 in Q1 2021.
- Funds reported $6.63M of Oragenics stock for Q2 2021, down 20% quarter-over-quarter.
- 4 funds opened new Oragenics positions in Q2 2021 and 10 closed out, a net change of -6 holders.
- The largest Oragenics buyer in Q2 2021 was Vanguard Group, an estimated $374K added.
- The largest Oragenics seller in Q2 2021 was Citadel Advisors, an estimated $336K sold.
Based on aggregated 13F filings for Q2 2021.